Semaglutide × Prime Peptides — Lab Test, March 2026
This lab doesn't publish a public lookup, so we can't confirm the certificate against the lab's own record. The document was reviewed before publication, but it rests on our review alone.
What portal verification means →Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Independent HPLC purity analysis of Semaglutide from Prime Peptides, performed by Vanguard Laboratory on March 25, 2026. Reported purity: 99.02%. Net content: 5.51 mg against 5 mg labeled (110% of label). Tested content exceeds the labeled amount by 10%. Endotoxins: <5.00 EU/mg. Batch 21222026SM. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion